Clinical trials of adenoviral-mediated suicide gene therapy of malignant gliomas.

[1]  A. Bout,et al.  Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity , 2000, Gene Therapy.

[2]  C. Fernández-Chacón.  Imaging of herpes simplex virus thymidine kinase (HSVtk) gene expression with positron emission tomography (PET) , 2000 .

[3]  F. Deist,et al.  Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. , 2000, Science.

[4]  M. Brenner.  Reports of adenovector "death" are greatly exaggerated. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  Alan McClelland,et al.  Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector , 2000, Nature Genetics.

[6]  R. Grossman,et al.  Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  M. Bewley,et al.  Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. , 1999, Science.

[8]  I. Kovesdi,et al.  Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. , 1999, Science.

[9]  D. Kirn,et al.  Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: Intratumoral spread and distribution effects , 1999, Cancer Gene Therapy.

[10]  H. Lassmann,et al.  Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials , 1999, Nature Medicine.

[11]  J. Knisely,et al.  Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  Sally Lehrman,et al.  Virus treatment questioned after gene therapy death , 1999, Nature.

[13]  L. Mariani,et al.  A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir , 1999 .

[14]  Susan M. Chang,et al.  Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Y. Chiang,et al.  A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma. , 1999, Human gene therapy.

[16]  C. Miller,et al.  A system for the propagation of adenoviral vectors with genetically modified receptor specificities , 1999, Nature Biotechnology.

[17]  J. Isner,et al.  Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. , 1999, The Journal of clinical investigation.

[18]  R. McLendon,et al.  Irinotecan therapy in adults with recurrent or progressive malignant glioma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  P. Lowenstein,et al.  Interleukin-1 Mediates a Rapid Inflammatory Response After Injection of Adenoviral Vectors into the Brain , 1999, The Journal of Neuroscience.

[20]  C. Miller,et al.  Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. , 1998, Cancer Research.

[21]  W. Ramsey,et al.  The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communication , 1998, Gene Therapy.

[22]  C. Miller,et al.  An Adenovirus Vector with Genetically Modified Fibers Demonstrates Expanded Tropism via Utilization of a Coxsackievirus and Adenovirus Receptor-Independent Cell Entry Mechanism , 1998, Journal of Virology.

[23]  D. Klatzmann,et al.  A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase "Suicide" Gene Therapy for Recurrent Glioblastoma , 1998 .

[24]  A. Bout,et al.  Intracerebral injection of adenovirus harboring the HSVtk gene combined with ganciclovir administration: toxicity study in nonhuman primates , 1998, Gene Therapy.

[25]  M. Prados,et al.  Survival and functional status after resection of recurrent glioblastoma multiforme. , 1998, Neurosurgery.

[26]  R. Sawaya.  Biology of Neurological Recovery and Functional Restoration after Spinal Cord Injury , 1998 .

[27]  J. Bergelson,et al.  The Murine CAR Homolog Is a Receptor for Coxsackie B Viruses and Adenoviruses , 1998, Journal of Virology.

[28]  H. Clevers,et al.  The human TRIDENT/HFH-11/FKHL16 gene: structure, localization, and promoter characterization. , 1997, Genomics.

[29]  Z. Ram,et al.  Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells , 1997, Nature Medicine.

[30]  A. Jacobs,et al.  Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy. , 1997, Human gene therapy.

[31]  C. Avezaat,et al.  Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies. , 1997, Neurosurgery.

[32]  J. Simons,et al.  Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. , 1997, Cancer research.

[33]  D. Hackney,et al.  Intracranial administration of adenovirus expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory response. , 1997, Human gene therapy.

[34]  R. Vile,et al.  Generation of an anti‐tumour immune response in a non‐immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1‐like profile of intratumoural cytokine expression , 1997, International journal of cancer.

[35]  S. Woo,et al.  Neurotoxicity of intracerebral injection of a replication-defective adenoviral vector in a semipermissive species (cotton rat) , 1997, Gene Therapy.

[36]  M. Wood,et al.  Immune responses to adenoviral vectors during gene transfer in the brain. , 1997, Human gene therapy.

[37]  I. Kovesdi,et al.  Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression , 1997, Journal of virology.

[38]  D. Curiel,et al.  Targeted gene delivery by tropism-modified adenoviral vectors , 1996, Nature Biotechnology.

[39]  A. Fattaey,et al.  An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells , 1996, Science.

[40]  D. Curiel,et al.  Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism , 1996, Journal of virology.

[41]  A. Alavi,et al.  Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial. , 1996, Human gene therapy.

[42]  M. Wood,et al.  Role of T cells in inflammation caused by adenovirus vectors in the brain. , 1996, Gene therapy.

[43]  R. Grossman,et al.  Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies. , 1996, Human gene therapy.

[44]  W. Hamel,et al.  Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. , 1996, Cancer research.

[45]  P. Dirks,et al.  Analysis of glial fibrillary acidic protein gene methylation in human malignant gliomas. , 1996, Anticancer research.

[46]  A. Fischer,et al.  Bone marrow gene transfer in three patients with adenosine deaminase deficiency. , 1996, Gene therapy.

[47]  C. Avezaat,et al.  Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors. , 1996, Human gene therapy.

[48]  S. Rosenberg,et al.  T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years , 1995, Science.

[49]  R. Crystal,et al.  Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis , 1994, Nature Genetics.

[50]  T. Shawker,et al.  The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. , 1994, Journal of neurosurgery.

[51]  R. Grossman,et al.  Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[52]  M. Bernstein,et al.  The value of reoperation for recurrent glioblastoma. , 1993, Canadian journal of surgery. Journal canadien de chirurgie.

[53]  G. Nemerow,et al.  Integrins α v β 3 and α v β 5 promote adenovirus internalization but not virus attachment , 1993, Cell.

[54]  Z. Ram,et al.  In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. , 1992, Science.

[55]  K. Wallner,et al.  Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. , 1989, International journal of radiation oncology, biology, physics.

[56]  P. Gutin,et al.  Reoperation for recurrent glioblastoma and anaplastic astrocytoma. , 1987, Neurosurgery.

[57]  M. Mikhael,et al.  Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. , 1987, Neurosurgery.

[58]  R. Huebner,et al.  Studies on the use of viruses in the treatment of carcinoma of the cervix , 1956 .

[59]  J. Coebergh,et al.  Incidence of Cancer in the Netherlands 1998 , 2002 .

[60]  J. H. Kim,et al.  Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization. , 2000, Human gene therapy.

[61]  O. Wildner,et al.  Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer , 1999, Gene Therapy.

[62]  J. Caro,et al.  Hypoxia regulatory elements of the human vascular endothelial growth factor gene. , 1994, Cellular & molecular biology research.

[63]  M. Berger,et al.  Reoperation for glioma. , 1992, Clinical neurosurgery.

[64]  M. Levine,et al.  Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine. , 1992, Vaccine.

[65]  K. Berkner.  Expression of heterologous sequences in adenoviral vectors. , 1992, Current topics in microbiology and immunology.

[66]  P. Burger.  Pathologie Anatomy and CT Correlations in the Glioblastoma Multif orme , 1983 .